New Cholesterol-lowering Drugs Help Those Intolerant to Statins
PCSK9 inhibitors may also bring about changes to cholesterol treatment guidelines that have moved away from specific LDL targets for patients.
Two new cholesterol-lowering drugs may do more than provide alternatives for people who have serious side effects from statins. PCSK9 inhibitors may also help bring back specific targets in cholesterol treatment guidelines. When the American College of Cardiology and the American Heart Association developed new cholesterol guidelines with the National Heart, Lung, and Blood Institute in 2013, the changes included the eliminiation of specific targets for LDL (“bad”) cholesterol and HDL (“good”) cholesterol.